tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
US Market

Ligand Pharma (LGND) Technical Analysis

Compare
805 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Ligand Pharma’s (LGND) Moving Averages Convergence Divergence (MACD) indicator is 0.56, suggesting Ligand Pharma is a Buy.
Ligand Pharma’s (LGND) 20-Day exponential moving average is 116.93, while Ligand Pharma’s (LGND) share price is $112.18, making it a Sell.
Ligand Pharma’s (LGND) 50-Day exponential moving average is 115.61, while Ligand Pharma’s (LGND) share price is $112.18, making it a Sell.

Ligand Pharma (LGND) Pivot Points

Mar 04, 2025, 12:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
111.36
113.54
117.88
120.06
124.41
126.59
130.93
Fibonacci
113.54
116.03
117.57
120.06
122.55
124.09
126.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ligand Pharma (LGND) Moving Averages

Mar 04, 2025, 12:18 PM
Period
Simple
Exponential
MA5
116.76Sell
116.55Sell
MA10
118.55Sell
117.18Sell
MA20
117.01Sell
116.93Sell
MA50
114.44Sell
115.61Sell
MA100
114.21Sell
112.44Sell
MA200
104.64Buy
102.57Buy
Ligand Pharma’s (LGND) 10-Day exponential moving average is 117.18, while Ligand Pharma’s (LGND) share price is $112.18, making it a Sell.
Ligand Pharma’s (LGND) 100-Day exponential moving average is 112.44, while Ligand Pharma’s (LGND) share price is $112.18, making it a Sell.
Ligand Pharma’s (LGND) stock price is $112.18 and Ligand Pharma’s (LGND) 50-day simple moving average is 114.44, creating a Sell signal.
Ligand Pharma’s (LGND) stock price is $112.18 and Ligand Pharma’s (LGND) 100-day simple moving average is 114.21, creating a Sell signal.
Ligand Pharma’s (LGND) stock price is $112.18 and Ligand Pharma’s (LGND) 200-day simple moving average is 104.64, creating a Buy signal.

Ligand Pharma (LGND) Technical Indicators

Mar 04, 2025, 12:18 PM
Name
Value
Implied Action
RSI (14)
43.85
Neutral
STOCH (9,6)
45.65
Neutral
STOCHRSI (14)
48.25
Neutral
MACD (12,26)
0.56
Buy
ADX (14)
17.11
Buy
Williams %R
-85.63
Buy
CCI (14)
-39.59
Neutral
ATR (14)
5.63
-
Ultimate Oscillator
41.17
Neutral
ROC
-1.70
Sell
Ligand Pharma’s (LGND) Relative Strength Index (RSI) is 43.85, creating a Neutral signal.
Ligand Pharma’s (LGND) Trend Strength Indicator (ADX) is 17.11, creating a Buy signal.
Ligand Pharma’s (LGND) Commodity Channel Index (CCI) is -39.59, creating a Neutral signal.
Ligand Pharma’s (LGND) Price Rate of Change (ROC) is -1.70, creating a Sell signal.

FAQ

Is LGND a Buy, Hold, or Sell?
Based on LGND’s technical indicators, LGND is a Sell.
    What is LGND’s RSI (14)?
    LGND’s RSI (14) is 43.85, which suggests LGND is a Neutral.
      What is LGND’s MACD?
      LGND’s MACD is 0.56, which suggests LGND is a Buy.
        What is LGND’s 5-day moving average?
        LGND’s 5-day moving average is 116.76, which suggests LGND is a Sell.
          What is LGND’s 20-day moving average?
          LGND 20-day moving average is 117.01, which suggests LGND is a Sell.
            What is LGND’s 50-day moving average?
            LGND’s 50-day moving average is 114.44, which suggests LGND is a Sell.
              What is LGND’s 200-day moving average?
              LGND’s 200-day moving average is 104.64, which suggests LGND is a Buy.
                What is LGND’s Williams % R (14)?
                LGND’s Williams % R (14) is -85.63, which suggests LGND is a Buy.
                  What is LGND’s CCI (14)?
                  LGND’s CCI (14) is -39.59, which suggests LGND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis